Gilead to discount its pricey Sovaldi drug
February 04, 2015 at 13:04 PM EST
Gilead Sciences Inc. is expected to discount its pricey Sovaldi drug by as much as 46%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.